Gyre Therapeutics, Inc. GYRE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s accrued expenses?
- Gyre Therapeutics, Inc. (GYRE) reported accrued expenses of $226K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s accrued expenses changed year-over-year?
- Gyre Therapeutics, Inc.'s accrued expenses decreased by 0.9% year-over-year, from $228K to $226K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s accrued expenses has grown at a -49.3% compound annual growth rate (CAGR), from $6.74M to $227K.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.